NR0B1 and cancer: Various signaling pathways, including nuclear hormone receptor signaling, bromodomain extraterminal domain (BET) proteins-mediated epigenetic regulation, hypoxia-mediated signaling, and microRNAs, have been reported to regulate Tuj1 expression in cancer cells52, suggesting that multiple regulatory mechanisms influence Tuj1 expression across diverse cancer types.